Results 101 to 110 of about 17,407,911 (333)

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

open access: yesMolecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou   +11 more
wiley   +1 more source

Europe's clean technology investment challenge [PDF]

open access: yes
Development and deployment of clean-energy technologies is crucial if climate targets are to be met cost-effectively. The European Union already has a plan that deals with these issues: the Strategic Energy Technology Plan, which has become central to ...
Reinhilde Veugelers
core   +1 more source

UNICORE Workflow Management Evaluation Report [PDF]

open access: yes, 2016
The Technology Investigation Service's Technology Evaluation team conducted an evaluation of the Unicore Workflow Management system.
The Technology Investigation Service's Technology Evaluation Team
core  

Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer

open access: yesMolecular Oncology, EarlyView.
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu   +7 more
wiley   +1 more source

Retracted: Semiconductor Polymer Carbon Composite Coated Fabric for Warm Beds in Hospital

open access: yesAdsorption Science & Technology, 2023
Adsorption Science and Technology
doaj   +1 more source

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

open access: yesMolecular Oncology, EarlyView.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy   +12 more
wiley   +1 more source

Bittorrent Sync Evaluation Public Report [PDF]

open access: yes, 2016
The Technology Investigation Service's Technology Evaluation team conducted an evaluation of the BitTorrent file transfer tool.
The Technology Investigation Service's Technology Evaluation Team
core  

Home - About - Disclaimer - Privacy